{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T12:44:24Z","timestamp":1648644264272},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,8,9]],"date-time":"2012-08-09T00:00:00Z","timestamp":1344470400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s12282-012-0389-3","type":"journal-article","created":{"date-parts":[[2012,8,8]],"date-time":"2012-08-08T08:11:16Z","timestamp":1344413476000},"page":"140-145","source":"Crossref","is-referenced-by-count":5,"title":["Clinicopathological study of non-palpable familial breast cancer detected by screening mammography and diagnosed as DCIS"],"prefix":"10.1007","volume":"21","author":[{"given":"Motonobu","family":"Saito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Katagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiaki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron J.","family":"Schetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichi","family":"Takenoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Nomizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,9]]},"reference":[{"issue":"12","key":"389_CR1","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893\u2013917.","journal-title":"Int J Cancer"},{"key":"389_CR2","doi-asserted-by":"crossref","unstructured":"Nomizu T, Sakuma T, Yamada M, Matsuzaki M, Katagata N, Watanabe F, et al. Three cases of kindred with familial breast cancer in which carrier detection by BRCA gene testing was performed on family members. Breast Cancer. 2009. doi: 10.1007\/s12282-009-0157-1 .","DOI":"10.1007\/s12282-009-0157-1"},{"key":"389_CR3","doi-asserted-by":"crossref","unstructured":"Adem C, Jenkins RB, Capron F, Stoppa-Lyonnet D. High-risk lesions in high-risk women: a high-risk formalin-based biology! J Clin Oncol 2004;22:1159\u201361 (author reply 1152\u201361).","DOI":"10.1200\/JCO.2004.99.193"},{"key":"389_CR4","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1200\/JCO.2005.04.0345","volume":"25","author":"ES Hwang","year":"2007","unstructured":"Hwang ES, McLennan JL, Moore DH, Crawford BB, Esserman LJ, Ziegler JL. Ductal carcinoma in situ in BRCA mutation carriers. J Clin Oncol. 2007;25:642\u20137.","journal-title":"J Clin Oncol"},{"key":"389_CR5","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1158\/1078-0432.CCR-07-0146","volume":"13","author":"KL Smith","year":"2007","unstructured":"Smith KL, Adank M, Kauff N, Lafaro K, Boyd J, Lee JB, et al. BRCA mutations in women with ductal carcinoma in situ. Clin Cancer Res. 2007;13:4306\u201310.","journal-title":"Clin Cancer Res"},{"key":"389_CR6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF02966513","volume":"4","author":"T Nomizu","year":"1997","unstructured":"Nomizu T, Tsuchiya A, Kanno M, Katagata N, Watanabe F, Yamaki Y, et al. Clinicopathological features of hereditary breast cancer. Breast Cancer. 1997;4:239\u201342.","journal-title":"Breast Cancer"},{"key":"389_CR7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s100380050035","volume":"43","author":"T Katagiri","year":"1998","unstructured":"Katagiri T, Kasumi F, Yoshimoto M, Nomizu T, Asaishi K, Abe R, et al. High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families. J Hum Genet. 1998;43:42\u20138.","journal-title":"J Hum Genet"},{"key":"389_CR8","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3346\/jkms.2011.26.3.352","volume":"26","author":"D Kim","year":"2011","unstructured":"Kim D, Jung W, Koo JS. The expression of ERCC1, RRM1, and BRCA1 in breast cancer according to the immunohistochemical phenotypes. J Korean Med Sci. 2011;26:352\u20139.","journal-title":"J Korean Med Sci"},{"key":"389_CR9","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.20.6.1480","volume":"20","author":"TS Frank","year":"2002","unstructured":"Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol. 2002;20:1480\u201390.","journal-title":"J Clin Oncol"},{"key":"389_CR10","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1200\/JCO.2009.27.2294","volume":"28","author":"AJ Rijnsburger","year":"2010","unstructured":"Rijnsburger AJ, Obdeijn IM, Kaas R, Tilanus-Linthorst MM, Boetes C, Loo CE, et al. BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study. J Clin Oncol. 2010;28:5265\u201373.","journal-title":"J Clin Oncol"},{"key":"389_CR11","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nrclinonc.2010.166","volume":"7","author":"SA Narod","year":"2010","unstructured":"Narod SA. BRCA mutations in the management of breast cancer: the state of the art. Nat Rev Clin Oncol. 2010;7:702\u20137.","journal-title":"Nat Rev Clin Oncol"},{"key":"389_CR12","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.4065\/mcp.2010.0414","volume":"85","author":"S Pruthi","year":"2010","unstructured":"Pruthi S, Gostout BS, Lindor NM. Identification and management of women with BRCA mutations or hereditary predisposition for breast and ovarian cancer. Mayo Clin Proc. 2010;85:1111\u201320.","journal-title":"Mayo Clin Proc"},{"key":"389_CR13","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0140-6736(02)08434-9","volume":"359","author":"BG Haffty","year":"2002","unstructured":"Haffty BG, Harrold E, Khan AJ, Pathare P, Smith TE, Turner BC, et al. Outcome of conservatively managed early-onset breast cancer by BRCA1\/2 status. Lancet. 2002;359:1471\u20137.","journal-title":"Lancet"},{"key":"389_CR14","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1200\/JCO.2005.02.7888","volume":"24","author":"LJ Pierce","year":"2006","unstructured":"Pierce LJ, Levin AM, Rebbeck TR, Ben-David MA, Friedman E, Solin LJ, et al. Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1\/2-associated stage I\/II breast cancer. J Clin Oncol. 2006;24:2437\u201343.","journal-title":"J Clin Oncol"},{"key":"389_CR15","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.ejca.2005.02.037","volume":"41","author":"YM Kirova","year":"2005","unstructured":"Kirova YM, Stoppa-Lyonnet D, Savignoni A, Sigal-Zafrani B, Fabre N, Fourquet A. Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy. Eur J Cancer. 2005;41:2304\u201311.","journal-title":"Eur J Cancer"},{"key":"389_CR16","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/0003-4819-143-5-200509060-00012","volume":"143","author":"HD Nelson","year":"2005","unstructured":"Nelson HD, Huffman LH, Fu R, Harris EL. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2005;143:362\u201379.","journal-title":"Ann Intern Med"},{"key":"389_CR17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0900212","volume":"361","author":"PC Fong","year":"2009","unstructured":"Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med. 2009;361:123\u201334.","journal-title":"N Engl J Med"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-012-0389-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12282-012-0389-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-012-0389-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T16:36:40Z","timestamp":1562085400000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12282-012-0389-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,9]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["389"],"URL":"https:\/\/doi.org\/10.1007\/s12282-012-0389-3","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,9]]}}}